296766-98-8

Basic information

• Product Name: 2,6-DIFLUORO-N-HYDROXY-BENZAMIDINE
• Synonyms: 2,6-DIFLUORO-N-HYDROXY-BENZAMIDINE
• CAS NO: 296766-98-8
• Molecular Formula: C₇H₆F₂N₂O
• Molecular Weight: 172.13
• Product Categories: pharmacetical
• Mol File: 296766-98-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 301.2 °C at 760 mmHg
• Flash Point: 135.9 °C
• Appearance: /
• Density: 1.41 g/cm³
• CAS DataBase Reference: 2,6-DIFLUORO-N-HYDROXY-BENZAMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-DIFLUORO-N-HYDROXY-BENZAMIDINE(296766-98-8)
• EPA Substance Registry System: 2,6-DIFLUORO-N-HYDROXY-BENZAMIDINE(296766-98-8)

Safety Data

• Hazardous Substances Data: 296766-98-8(Hazardous Substances Data)

Usage

General Description

2,6-Difluoro-N-hydroxy-benzamidine is a chemical compound with the molecular formula C7H6F2N2O. It belongs to the benzamidine class of compounds and is a derivative of benzanilide. This chemical is used as a pharmaceutical intermediate in the synthesis of various pharmaceuticals and organic compounds. It is also utilized in research and development for its potential applications in the medical and pharmaceutical industries. 2,6-Difluoro-N-hydroxy-benzamidine may have potential medicinal properties and is studied for its effects on various biological processes and targeted enzyme inhibition. Overall, this chemical compound has diverse applications and is a valuable component in the pharmaceutical and medical research fields.

Upstream product

• 1897-52-5 2,6 difluorobenzonitrile 

Downstream Products

• 1442483-75-1 3-bromo-N-(2-(3-(2,6-difluorophenyl)-1,2,4-oxadiazol-5-yl)-4-chloro-6-methylphenyl)-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide 

Relevant articles and documents

KCNT1 INHIBITORS AND METHODS OF USE

The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.

3-(2,6-difluorophenyl)-1,2,4-oxadiazole compound and application thereof

The invention provides a 3-(2,6-difluorophenyl)-1,2,4-oxadiazole compound insecticide/acaricide with a structure as shown in a general formula I in the specification, wherein R is as shown in the specification. The compound as shown in the general formula

TRIAZOLE OXADIAZOLES DERIVATIVES

The invention relates to compounds of formula (I), wherein R1, R2, Ra, Rb, X have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.